Received Jun 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | X019196 | — |
Nurse confirmed the patient involved has not reported any medical concerns or symptoms after being administered the expired dose of GARDASIL 9. No additional AE; expired administration of a dose of GARDASIL 9; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, past drug reactions and allergies were not reported. On 16-JUN-2025, the patient was inadvertently vaccinated with an expired vaccine of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) prefilled syringe, 0.5 mL, Two or Three dose series, administered as prophylaxis (lot number X019196 has been verified to be valid for Human Papillomavirus 9-valent Vaccine, Recombinant [GARDASIL 9], expiration date 25-APR-2025; dose, formulation, anatomical site of injection, and route of administration were not reported) (Expired product administered). Nurse confirmed the patient involved has not reported any medical concerns or symptoms after being administered the expired dose of the vaccine (No adverse event). No additional information provided.